We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.3B
AUM Growth
-$128M
Cap. Flow
-$697M
Cap. Flow %
-6.16%
Top 10 Hldgs %
41.41%
Holding
1,243
New
52
Increased
320
Reduced
317
Closed
40

Sector Composition

Rank Sector Weight
1 Real Estate 72.31%
2 Technology 4.13%
3 Industrials 3.02%
4 Financials 2.93%
5 Healthcare 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTMX icon
1101
CytomX Therapeutics
CTMX
$705M
$3K ﹤0.01%
285
+73
+34% +$765
DNTH icon
1102
Dianthus Therapeutics
DNTH
$5.68B
$3K ﹤0.01%
14
EOLS icon
1103
Evolus
EOLS
$394M
$3K ﹤0.01%
173
CBIO
1104
Crescent Biopharma
CBIO
$602M
$3K ﹤0.01%
3
MNOV icon
1105
MediciNova
MNOV
$65M
$3K ﹤0.01%
268
PBYI icon
1106
Puma Biotechnology
PBYI
$406M
$3K ﹤0.01%
243
REPL icon
1107
Replimune Group
REPL
$814M
$3K ﹤0.01%
201
SIGA icon
1108
SIGA Technologies
SIGA
$223M
$3K ﹤0.01%
511
UBX
1109
DELISTED
Unity Biotechnology
UBX
$3K ﹤0.01%
27
CBAY
1110
DELISTED
Cymabay Therapeutics
CBAY
$3K ﹤0.01%
378
CCXI
1111
DELISTED
ChemoCentryx, Inc.
CCXI
$3K ﹤0.01%
365
+96
+36% +$1.11K
FLXN
1112
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3K ﹤0.01%
207
PGNX
1113
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$3K ﹤0.01%
533
+145
+37% +$699
DERM
1114
DELISTED
Dermira, Inc.
DERM
$3K ﹤0.01%
269
PDLI
1115
DELISTED
PDL BioPharma, Inc.
PDLI
$3K ﹤0.01%
853
ACET icon
1116
Adicet Bio
ACET
$72.8M
$2K ﹤0.01%
2
ACIU icon
1117
AC Immune
ACIU
$227M
$2K ﹤0.01%
+425
New +$2.17K
AUTL
1118
Autolus Therapeutics
AUTL
$386M
$2K ﹤0.01%
115
CLLS
1119
Cellectis
CLLS
$286M
$2K ﹤0.01%
100
COLL icon
1120
Collegium Pharmaceutical
COLL
$1.14B
$2K ﹤0.01%
180
KNSA icon
1121
Kiniksa Pharmaceuticals
KNSA
$4.83B
$2K ﹤0.01%
117
KPTI icon
1122
Karyopharm Therapeutics
KPTI
$168M
$2K ﹤0.01%
26
+9
+53% +$723
OPTN
1123
DELISTED
OptiNose
OPTN
$2K ﹤0.01%
18
PRQR icon
1124
ProQR Therapeutics
PRQR
$243M
$2K ﹤0.01%
246
PRTA icon
1125
Prothena Corp
PRTA
$458M
$2K ﹤0.01%
212

Similar funds

Daiwa Securities Group's Q2 2019 Portfolio in Review

As of Q2 2019, Daiwa Securities Group held 1,243 positions worth $11.3B, down 1.1% from $11.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group withdrew a net $697M in Q2 2019, closing 40 positions and reducing 317 holdings. Its most notable exit was L3Harris, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 74% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Coupa Software Incorporated worth $4.17M.

  • Daiwa Securities Group's largest Q2 2019 buy was Coupa Software Incorporated: 32,900 shares worth $4.17M.
  • Daiwa Securities Group added most to Host Hotels & Resorts in Q2 2019, an estimated $98.9M increase.
  • Daiwa Securities Group's biggest Q2 2019 reduction was Digital Realty Trust, cutting an estimated $144M.
  • Daiwa Securities Group fully exited L3Harris in Q2 2019, selling an estimated $3.77M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11.3B portfolio in Q2 2019.
  • Daiwa Securities Group opened 52 new positions and closed 40 in Q2 2019.
  • Daiwa Securities Group's portfolio value fell 1.1% quarter-over-quarter to $11.3B.

Based on Daiwa Securities Group's 13F filing for Q2 2019, filed 24 Jul 2019.